Previous investigations demonstrated that FGF21 levels increased in mild and moderate NAFLD patients but as hepatic fat content increased and severe NAFLD occurred FGF21 concentration decreased. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.